Logo image of QGEN

QIAGEN N.V. (QGEN) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:QGEN - NL0015002SN0 - Common Stock

55.62 USD
+1.37 (+2.53%)
Last: 1/23/2026, 8:04:00 PM
55.62 USD
0 (0%)
After Hours: 1/23/2026, 8:04:00 PM
Fundamental Rating

6

QGEN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. QGEN gets an excellent profitability rating and is at the same time showing great financial health properties. QGEN has a decent growth rate and is not valued too expensively. With these ratings, QGEN could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • QGEN had positive earnings in the past year.
  • In the past year QGEN had a positive cash flow from operations.
  • In the past 5 years QGEN has always been profitable.
  • Each year in the past 5 years QGEN had a positive operating cash flow.
QGEN Yearly Net Income VS EBIT VS OCF VS FCFQGEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 6.19%, QGEN belongs to the top of the industry, outperforming 82.46% of the companies in the same industry.
  • QGEN has a Return On Equity of 11.11%. This is amongst the best in the industry. QGEN outperforms 82.46% of its industry peers.
  • With a decent Return On Invested Capital value of 7.44%, QGEN is doing good in the industry, outperforming 78.95% of the companies in the same industry.
  • QGEN had an Average Return On Invested Capital over the past 3 years of 7.25%. This is significantly below the industry average of 13.75%.
  • The 3 year average ROIC (7.25%) for QGEN is below the current ROIC(7.44%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.19%
ROE 11.11%
ROIC 7.44%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
QGEN Yearly ROA, ROE, ROICQGEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 19.58%, QGEN belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
  • In the last couple of years the Profit Margin of QGEN has declined.
  • With an excellent Operating Margin value of 27.02%, QGEN belongs to the best of the industry, outperforming 96.49% of the companies in the same industry.
  • In the last couple of years the Operating Margin of QGEN has grown nicely.
  • QGEN has a better Gross Margin (64.10%) than 85.96% of its industry peers.
  • In the last couple of years the Gross Margin of QGEN has remained more or less at the same level.
Industry RankSector Rank
OM 27.02%
PM (TTM) 19.58%
GM 64.1%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
QGEN Yearly Profit, Operating, Gross MarginsQGEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), QGEN is destroying value.
  • Compared to 1 year ago, QGEN has less shares outstanding
  • QGEN has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for QGEN has been reduced compared to a year ago.
QGEN Yearly Shares OutstandingQGEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
QGEN Yearly Total Debt VS Total AssetsQGEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • QGEN has an Altman-Z score of 3.94. This indicates that QGEN is financially healthy and has little risk of bankruptcy at the moment.
  • QGEN has a better Altman-Z score (3.94) than 68.42% of its industry peers.
  • QGEN has a debt to FCF ratio of 4.50. This is a neutral value as QGEN would need 4.50 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 4.50, QGEN is doing good in the industry, outperforming 73.68% of the companies in the same industry.
  • A Debt/Equity ratio of 0.45 indicates that QGEN is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.45, QGEN is not doing good in the industry: 63.16% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.5
Altman-Z 3.94
ROIC/WACC0.89
WACC8.33%
QGEN Yearly LT Debt VS Equity VS FCFQGEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • QGEN has a Current Ratio of 2.60. This indicates that QGEN is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.60, QGEN is in line with its industry, outperforming 49.12% of the companies in the same industry.
  • QGEN has a Quick Ratio of 2.30. This indicates that QGEN is financially healthy and has no problem in meeting its short term obligations.
  • QGEN has a Quick ratio (2.30) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 2.3
QGEN Yearly Current Assets VS Current LiabilitesQGEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 12.41% over the past year.
  • The Earnings Per Share has been growing slightly by 7.92% on average over the past years.
  • The Revenue has been growing slightly by 5.32% in the past year.
  • QGEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.32% yearly.
EPS 1Y (TTM)12.41%
EPS 3Y-7.35%
EPS 5Y7.92%
EPS Q2Q%9.52%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%

3.2 Future

  • Based on estimates for the next years, QGEN will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.41% on average per year.
  • QGEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.12% yearly.
EPS Next Y13.29%
EPS Next 2Y9.93%
EPS Next 3Y9.85%
EPS Next 5Y9.41%
Revenue Next Year5%
Revenue Next 2Y5.54%
Revenue Next 3Y5.77%
Revenue Next 5Y7.12%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
QGEN Yearly Revenue VS EstimatesQGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
QGEN Yearly EPS VS EstimatesQGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

  • QGEN is valuated rather expensively with a Price/Earnings ratio of 22.61.
  • Based on the Price/Earnings ratio, QGEN is valued cheaply inside the industry as 87.72% of the companies are valued more expensively.
  • QGEN is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 20.59, the valuation of QGEN can be described as rather expensive.
  • QGEN's Price/Forward Earnings ratio is rather cheap when compared to the industry. QGEN is cheaper than 87.72% of the companies in the same industry.
  • QGEN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.26, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.61
Fwd PE 20.59
QGEN Price Earnings VS Forward Price EarningsQGEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 85.96% of the companies in the same industry are more expensive than QGEN, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of QGEN indicates a rather cheap valuation: QGEN is cheaper than 80.70% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 25.53
EV/EBITDA 16.23
QGEN Per share dataQGEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • QGEN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.7
PEG (5Y)2.86
EPS Next 2Y9.93%
EPS Next 3Y9.85%

2

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.49%, QGEN is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.09, QGEN pays a better dividend. On top of this QGEN pays more dividend than 94.74% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, QGEN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.49%

5.2 History

  • QGEN does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
QGEN Yearly Dividends per shareQGEN Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y9.93%
EPS Next 3Y9.85%
QGEN Yearly Income VS Free CF VS DividendQGEN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

QIAGEN N.V. / QGEN FAQ

Can you provide the ChartMill fundamental rating for QIAGEN N.V.?

ChartMill assigns a fundamental rating of 6 / 10 to QGEN.


Can you provide the valuation status for QIAGEN N.V.?

ChartMill assigns a valuation rating of 5 / 10 to QIAGEN N.V. (QGEN). This can be considered as Fairly Valued.


What is the profitability of QGEN stock?

QIAGEN N.V. (QGEN) has a profitability rating of 8 / 10.


What is the earnings growth outlook for QIAGEN N.V.?

The Earnings per Share (EPS) of QIAGEN N.V. (QGEN) is expected to grow by 13.29% in the next year.